Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

NCT00044720 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

484

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Failure
Graft vs Host Disease
Kidney Transplantation

Interventions

DRUG: Rapamune

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer